PBFCX
Price
$10.40
Change
-$0.01 (-0.10%)
Updated
Aug 6 closing price
Net Assets
854.61M
PNYPX
Price
$10.40
Change
-$0.01 (-0.10%)
Updated
Aug 6 closing price
Net Assets
854.61M
Interact to see
Advertisement

PBFCX vs PNYPX

Header iconPBFCX vs PNYPX Comparison
Open Charts PBFCX vs PNYPXBanner chart's image
PIMCO NY Municipal C
Price$10.40
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets854.61M
PIMCO NY Municipal I2
Price$10.40
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets854.61M
PBFCX vs PNYPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PBFCX vs. PNYPX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBFCX is a Hold and PNYPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PBFCX (855M) and PNYPX (855M) have equal amount of cash in the bank . PNYPX pays higher dividends than PBFCX: PNYPX (3.59) vs PBFCX (2.58). PBFCX was incepted earlier than PNYPX: PBFCX (16 years) vs PNYPX (15 years). PBFCX (1.52) is less costly to investors than PNYPX (0.55). PBFCX (14.00) and PNYPX (14.00) have comparable annual turnover. PBFCX has a lower initial minimum investment than PNYPX: PBFCX (1000) vs PNYPX (1000000). PNYPX annual gain was more profitable for investors over the last year : -1.56 vs. PBFCX (-2.52). PNYPX return over 5 years is better than : -0.50 vs. PBFCX (-4.41).
PBFCXPNYPXPBFCX / PNYPX
Total Expense Ratio1.520.55280%
Annual Report Gross Expense Ratio1.520.55280%
Fund Existence16 years15 years-
Gain YTD-2.019-1.458138%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets855M855M100%
Annual Yield % from dividends2.583.5972%
Returns for 1 year-2.52-1.56162%
Returns for 3 years2.294.9546%
Returns for 5 years-4.41-0.50883%
Returns for 10 years9.7819.5550%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTEV51.1411.62
+29.40%
Claritev Corporation
EXAS46.91-0.45
-0.95%
Exact Sciences Corp
TCRX1.73-0.02
-1.14%
TScan Therapeutics
AMN17.22-0.27
-1.54%
AMN Healthcare Services
HSDT5.55-0.35
-5.93%
Helius Medical Technologies Inc